What does DR. JORIS DE BONDT,CARDIOLOGIE do?

DR. JORIS DE BONDT,CARDIOLOGIE is a specialist medical practice in Nijlen. Private Limited, started on 29 October 2007, 1 establishment.

What is the address of DR. JORIS DE BONDT,CARDIOLOGIE?

The registered office of DR. JORIS DE BONDT,CARDIOLOGIE is located at Vogelzangstraat 24, 2560 Nijlen.

Is DR. JORIS DE BONDT,CARDIOLOGIE still active?

Yes. According to the CBE (16 September 2026) DR. JORIS DE BONDT,CARDIOLOGIE is active, legal situation “Normale toestand”, started on 29 October 2007.

Is DR. JORIS DE BONDT,CARDIOLOGIE registered on Peppol?

Yes, DR. JORIS DE BONDT,CARDIOLOGIE is registered on the Peppol network with ID 0208:0893352875.

What is the enterprise number of DR. JORIS DE BONDT,CARDIOLOGIE?

The enterprise number of DR. JORIS DE BONDT,CARDIOLOGIE is BE0893352875.

When was DR. JORIS DE BONDT,CARDIOLOGIE founded?

DR. JORIS DE BONDT,CARDIOLOGIE was founded on 29 October 2007.

Who are the directors of DR. JORIS DE BONDT,CARDIOLOGIE?

According to the 2025 annual accounts, the directors of DR. JORIS DE BONDT,CARDIOLOGIE are: Joris De Bondt.

Is DR. JORIS DE BONDT,CARDIOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 October 2007; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. JORIS DE BONDT,CARDIOLOGIE make in 2025?

DR. JORIS DE BONDT,CARDIOLOGIE posted a profit after taxes of € 265,234 in financial year 2025.

What is the revenue of DR. JORIS DE BONDT,CARDIOLOGIE?

As a small company, DR. JORIS DE BONDT,CARDIOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 494,434.

How many employees does DR. JORIS DE BONDT,CARDIOLOGIE have?

According to the 2025 annual accounts, DR. JORIS DE BONDT,CARDIOLOGIE has 0 full-time equivalents (FTE).

DR. JORIS DE BONDT,CARDIOLOGIE (Private Limited) - Nijlen

Dossier DR. JORIS DE BONDT,CARDIOLOGIE, printed on 16 September 2026 from databakkes.be/en/0893352875/dr-joris-de-bondt-cardiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. JORIS DE BONDT,CARDIOLOGIE from Nijlen, company number BE0893352875, closed financial year 2025 with a result of € 265,234 after tax. For that financial year DR. JORIS DE BONDT,CARDIOLOGIE recorded a gross margin of € 494,434 and equity of € 1.4 million. Compared with financial year 2024, the result moved from € 236,313 to € 265,234. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Growing

€ 1.4 million

▲ 23% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 265,234

▲ 12% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 497,785

▲ 15% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.4 million.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 138,719

▲ 96% vs 2024

Of which on lease € 93,273.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 439,363

▼ 3% vs 2024

€ 94,017 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 4,252

▲ 29% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 49,097

▼ 22% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 349,283 Gross margin 2022: € 349,283 First fiscal year in the series	€ 397,047 Gross margin 2023: € 397,047 ▲ 14% vs 2022 (€ 349,283) Favourable step	€ 427,320 Gross margin 2024: € 427,320 ▲ 8% vs 2023 (€ 397,047) Favourable step	€ 494,434 Gross margin 2025: € 494,434 ▲ 16% vs 2024 (€ 427,320) Favourable step	▲ 16%
Profit after taxes	€ 194,548 Profit after taxes 2022: € 194,548 First fiscal year in the series	€ 212,708 Profit after taxes 2023: € 212,708 ▲ 9% vs 2022 (€ 194,548) Favourable step	€ 236,313 Profit after taxes 2024: € 236,313 ▲ 11% vs 2023 (€ 212,708) Favourable step	€ 265,234 Profit after taxes 2025: € 265,234 ▲ 12% vs 2024 (€ 236,313) Favourable step	▲ 12%
Equity	€ 714,793 Equity 2022: € 714,793 First fiscal year in the series	€ 927,500 Equity 2023: € 927,500 ▲ 30% vs 2022 (€ 714,793) Favourable step	€ 1,163,813 Equity 2024: € 1,163,813 ▲ 25% vs 2023 (€ 927,500) Favourable step	€ 1,429,048 Equity 2025: € 1,429,048 ▲ 23% vs 2024 (€ 1,163,813) Favourable step	▲ 23%
Total debts	€ 535,886 Total debts 2022: € 535,886 First fiscal year in the series	€ 618,628 Total debts 2023: € 618,628 ▲ 15% vs 2022 (€ 535,886) Unfavourable step	€ 528,163 Total debts 2024: € 528,163 ▼ 15% vs 2023 (€ 618,628) Favourable step	€ 526,358 Total debts 2025: € 526,358 Unchanged (€ 528,163) Favourable step
Cash	€ 311,883 Cash 2022: € 311,883 First fiscal year in the series	€ 311,227 Cash 2023: € 311,227 Unchanged (€ 311,883) Unfavourable step	€ 432,035 Cash 2024: € 432,035 ▲ 39% vs 2023 (€ 311,227) Favourable step	€ 497,785 Cash 2025: € 497,785 ▲ 15% vs 2024 (€ 432,035) Favourable step	▲ 15%
Land & buildings	€ 709,650 Land & buildings 2022: € 709,650 First fiscal year in the series	€ 1,064,469 Land & buildings 2023: € 1,064,469 ▲ 50% vs 2022 (€ 709,650) Unchanged	€ 1,070,505 Land & buildings 2024: € 1,070,505 ▲ 1% vs 2023 (€ 1,064,469) Unchanged	€ 992,447 Land & buildings 2025: € 992,447 ▼ 7% vs 2024 (€ 1,070,505) Unchanged	▼ 7%
Retained profit	€ 696,193 Retained profit 2022: € 696,193 First fiscal year in the series	€ 908,900 Retained profit 2023: € 908,900 ▲ 31% vs 2022 (€ 696,193) Favourable step	€ 1,145,213 Retained profit 2024: € 1,145,213 ▲ 26% vs 2023 (€ 908,900) Favourable step	€ 1,410,448 Retained profit 2025: € 1,410,448 ▲ 23% vs 2024 (€ 1,145,213) Favourable step	▲ 23%
Bank debt	€ 466,526 Bank debt 2022: € 466,526 First fiscal year in the series	€ 532,314 Bank debt 2023: € 532,314 ▲ 14% vs 2022 (€ 466,526) Unfavourable step	€ 453,637 Bank debt 2024: € 453,637 ▼ 15% vs 2023 (€ 532,314) Favourable step	€ 439,363 Bank debt 2025: € 439,363 ▼ 3% vs 2024 (€ 453,637) Favourable step	▼ 3%
Balance sheet total	€ 1,250,679 Balance sheet total 2022: € 1,250,679 First fiscal year in the series	€ 1,546,128 Balance sheet total 2023: € 1,546,128 ▲ 24% vs 2022 (€ 1,250,679) Unchanged	€ 1,691,976 Balance sheet total 2024: € 1,691,976 ▲ 9% vs 2023 (€ 1,546,128) Unchanged	€ 1,955,406 Balance sheet total 2025: € 1,955,406 ▲ 16% vs 2024 (€ 1,691,976) Unchanged	▲ 16%

Key figures of DR. JORIS DE BONDT,CARDIOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. JORIS DE BONDT,CARDIOLOGIE?

What happened at DR. JORIS DE BONDT,CARDIOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 2, 2026 New annual accounts for financial year 2025: profit of € 265,234 (▲ 12% vs 2024). Source: NBB ↗
Nov 7, 2007 New establishment in Nijlen. KBO
Oct 29, 2007 Start of the company according to the CBE. KBO

In short

From € 194,548 profit in 2022 to € 265,234 profit in 2025.

Paid € 369,072 in corporate taxes since 2022.

Best year ever: 2025, with € 265,234 profit.

Original PDFs at the National Bank ↗

A new publication or filing at DR. JORIS DE BONDT,CARDIOLOGIE? We notify you, reason included.

Follow DR. JORIS DE BONDT,CARDIOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Joris De Bondt

DR. JORIS DE BONDT,CARDIOLOGIE

Behind DR. JORIS DE BONDT,CARDIOLOGIE is Joris De Bondt.

See the full network in the app

Directors

According to the 2025 annual accounts

Joris De Bondt

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Vogelzangstraat 24

2560 Nijlen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0893.352.875
VAT number: BE 0893.352.875
Registered office: Vogelzangstraat 24, 2560 Nijlen
Names & denominations: DR. JORIS DE BONDT,CARDIOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 29 October 2007
Peppol: Active · Active since 8 Oct 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗